共 11 条
- [1] Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) : 4551 - 4556Ajani, Jaffer A.Winter, KathrynKomaki, RitsukoKelsen, David P.Minsky, Bruce D.Liao, ZhongxingBradley, JeffreyFromm, MitchelHornback, DavidWillett, Christopher G.
- [2] [Anonymous], 2010, PLAT CISPL PACK INS
- [3] Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (20) : 1695 - +Chen, YunYe, JinjunZhu, ZhengfeiZhao, WeixinZhou, JialiangWu, ChaoyangTang, HuarongFan, MinLi, LingLin, QinXia, YiLi, YunhaiLi, JianchengJia, HuixunLu, SaiquanZhang, ZhenZhao, Kuaile
- [4] Cancer Stem Cells in Esophageal Cancer and Response to Therapy[J]. CANCER, 2018, 124 (20) : 3962 - 3964Harada, KazutoPizzi, Melissa PoolShanbhag, Namita D.Song, ShumeiAjani, Jaffer A.Baba, Hideo
- [5] Integrated genomic characterization of oesophageal carcinoma[J]. NATURE, 2017, 541 (7636) : 169 - +Kim, JihunBowlby, ReanneMungall, Andrew J.Robertson, A. GordonOdze, Robert D.Cherniack, Andrew D.Shih, JuliannPedamallu, Chandra SekharCibulskis, CarrieDunford, AndrewMeier, Samuel R.Kim, JaegilRaphael, Benjamin J.Wu, Hsin-TaWong, Alexandra M.Willis, Joseph E.Bass, Adam J.Derks, SarahGarman, KatherineMcCall, Shannon J.Wiznerowicz, MaciejPantazi, AngelikiParfenov, MichaelThorsson, VesteinnShmulevich, IlyaDhankani, VarshaMiller, MichaelSakai, RyoWang, KennethSchultz, NikolausShen, RonglaiArora, ArshiWeinhold, NilsSanchez-Vega, FranciscoKelsen, David P.Zhang, JuliaFelau, InaDemchok, JohnRabkin, Charles S.Camargo, M. ConstanzaZenklusen, Jean ClaudeBowen, JayLeraas, KristenLichtenberg, Tara M.Curtis, ChristinaSeoane, Jose A.Ojesina, Akinyemi I.Beer, David G.Gulley, Margaret L.Pennathur, Arjun
- [6] YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer[J]. CLINICAL CANCER RESEARCH, 2019, 25 (07) : 2264 - 2277Li, FanXu, YanLiu, BoveySingh, Pankaj KumarZhao, WeiJin, JiankangHan, GuangchunScott, Ailing W.Dong, XiaochuanHuo, LongfeiMa, LangPizzi, Melissa PoolWang, YingLi, YuanHarada, KazutoXie, MinSkinner, Heath D.Ding, ShengWang, LinghuaKrishnan, SunilJohnson, Randy L.Song, ShumeiAjani, Jaffer A.
- [7] National Comprehensive Cancer Network, 2019, ES ES JUCT CANC VERS
- [8] Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (01): : 91 - 95Schnirer, IIKomaki, RYao, JCSwisher, SPutnam, JPisters, PWTRoth, JAAjani, JA
- [9] A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma[J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (02) : 443 - 454Song, ShumeiXie, MinScott, Ailing W.Jin, JiankangMa, LangDong, XiaochuanSkinner, Heath D.Johnson, Randy L.Ding, ShengAjani, Jaffer A.
- [10] A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis[J]. ACTA ONCOLOGICA, 2012, 51 (08) : 975 - 983Vogelius, Ivan R.Bentzen, Soren M.